Page 1423 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

996 PART 8: Renal and Metabolic Disorders

failure and other sympathomimetic effects can be treated with oral • Brent GA, Hershman JM. Thyroxine therapy in patients with
propranolol, 2 mg/kg per day in two or three divided doses. Caution severe nonthyroidal illnesses and low serum thyroxine concentra-
should be exercised in the use of propranolol because severe bradycardia tion. JCEM. 1986;62:1-8.
89
and hypoglycemia may result. Surgery and radioiodine treatment are
required after the initial drug control of thyrotoxicosis in infants with • Chuang CP, Jong YS, Wu CY, Lo HM. Impact of triiodothyronine
nonautoimmune hyperthyroidism. and N-terminal pro-B-type natriuretic peptide on the long-term
survival of critically ill patients with acute heart failure. Am J
Cardiol. 2014;113:845-850.
IODIDE-INDUCED THYROTOXICOSIS (JODBASEDOW) • Hardy G, Hardy I, Manzanares W. Selenium supplementation in
Iodide, in the form of dietary supplements or medication (eg, antitus- the critically ill. Nutr Clin Pract. February 2012;27(1):21-33.
sive agents, amiodarone, or contrast agents), can induce thyrotoxicosis, • Panzer C, Beazley R, Braverman L. Rapid preoperative preparation
especially in patients who are relatively iodide deficient. Treatment for severe hyperthyroid Graves’ disease. J Clin Endocrinol Metab.
requires special considerations because antithyroid drugs alone are slow May 2004;89(5):2142-2144.
to act because of a flooded iodine pool. To deplete the gland of iodine, • Toft AD, Irvine WJ, Sinclair I, McIntosh D, Seth J, Cameron EHD.
perchlorate must be added to the therapeutic regimen—particularly Thyroid function after surgical treatment of thyrotoxicosis. NEJM.
in amiodarone-induced thyrotoxicosis. Naturally, iodide treatment is 1978;298:643-647.
90
not indicated.
• Wartofsky L, Burman KD. Alterations in thyroid function in
patients with systemic illness: the “euthyroid sick syndrome”.
Endocr Rev. 1982;3:164-217.
• Wartofsky L. Thyrotoxic storm. In: Ingbar SH, Braverman LE, eds.
KEY REFERENCES The Thyroid. Philadelphia, PA: JP Lippincott; 1986:974.
• Barca-Mayo O, Liao XH, DiCosmo C, et al. Role of type 2 deiodin- • Zweig SB, Schlosser JR, Thomas SA, Levy CJ, Fleckman AM. Rectal
ase in response to acute lung injury (ALI) in mice. Proc Natl Acad administration of propylthiouracil in suppository form in patients
Sci U S A. December 6, 2011;108(49):E1321-E1329. with thyrotoxicosis and critical illness: case report and review of
• Bennett-Guerrero E, Jimenez JL, White WD, D’Amico EB, Baldwin literature. Endocr Pract. January-February 2006;12(1):43-47.
BI, Schwinn DA. Cardiovascular effects of intravenous triiodothy-
ronine in patients undergoing coronary artery bypass graft sur-
gery: a randomized, double-blind, placebo- controlled trial. Duke Acknowledgment: This work was supported by US Public Health
T3 study group. JAMA. March 6, 1996;275(9):687-692. Service Grants DK-02081, DK-15070, and RR-00055 and support from
• Bogazzi F, Bartalena L, Cosci C, et al. Treatment of Type II amiod- the Abrams and Esformes Funds.
arone-induced thyrotoxicosis by either iopanoic acid or glucocor-
ticoids: a prospective, randomized study. J Clin Endocrinol Metab. REFERENCES
May 2003;88(5):1999-2002.
Complete references available online at www.mhprofessional.com/hall

section08.indd 996 1/14/2015 8:28:39 AM